Finer Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.1M Sell
13,172
-440
-3% -$446K 6.08% 3
2025
Q4
$14.6M Sell
13,612
-798
-6% -$763K 7.08% 4
2025
Q3
$11M Sell
14,410
-154
-1% -$115K 5.48% 4
2025
Q2
$11.4M Sell
14,564
-434
-3% -$337K 6.07% 4
2025
Q1
$12.4M Sell
14,998
-513
-3% -$427K 7.42% 2
2024
Q4
$12M Sell
15,511
-454
-3% -$376K 6.86% 3
2024
Q3
$14.1M Sell
15,965
-570
-3% -$512K 8.73% 2
2024
Q2
$15M Sell
16,535
-310
-2% -$248K 9.66% 1
2024
Q1
$13.1M Sell
16,845
-799
-5% -$569K 8.61% 1
2023
Q4
$10.3M Sell
17,644
-299
-2% -$175K 7.66% 3
2023
Q3
$9.64M Sell
17,943
-52
-0.3% -$26.8K 7.71% 2
2023
Q2
$8.44M Sell
17,995
-311
-2% -$130K 6.59% 3
2023
Q1
$6.29M Sell
18,306
-298
-2% -$101K 5.31% 3
2022
Q4
$6.81M Sell
18,604
-256
-1% -$90.8K 6.37% 2
2022
Q3
$6.1M Sell
18,860
-43
-0.2% -$13.6K 6% 2
2022
Q2
$6.13M Sell
18,903
-865
-4% -$260K 5.59% 3
2022
Q1
$5.66M Sell
19,768
-121
-0.6% -$31.1K 4.62% 3
2021
Q4
$5.49M Buy
+19,889
New +$5.04M 4.56% 3

Other funds holding LLY

Finer Wealth Management's LLY Position: Q1 2026 in Review

Finer Wealth Management reduced its Eli Lilly (LLY) stake by 3.2% in Q1 2026, selling an estimated $446K and leaving 13,172 shares worth $12.1M. The position accounts for 6.08% of the portfolio, ranked #3.

Finer Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $15M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Finer Wealth Management held 13,172 shares of Eli Lilly worth $12.1M as of Q1 2026.
  • Finer Wealth Management sold 440 Eli Lilly shares in Q1 2026, an estimated $446K.
  • Eli Lilly made up 6.08% of Finer Wealth Management's portfolio in Q1 2026, its #3 holding.
  • Finer Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Finer Wealth Management's Eli Lilly position peaked at $15M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Finer Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.